Skip to main content

Dallas-based Taysha Gene Therapies names board chair as new CEO

Sean P. Nolan, the chair of Taysha’s board, has been appointed CEO, succeeding RA Session II. Session resigned from his operational role but will continue on the board, according to a news release.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.